These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19755222)

  • 41. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
    Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
    Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials.
    Pandit A; Aryal MR; Pandit AA; Jalota L; Kantharajpur S; Hakim FA; Lee HR
    Heart Lung Circ; 2014 Apr; 23(4):303-8. PubMed ID: 24495944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Device closure of residual shunt after percutaneous closure of patent foramen ovale.
    Majunke N; Wallenborn J; Baranowski A; Wunderlich N; Sievert H
    EuroIntervention; 2010 Feb; 5(7):833-7. PubMed ID: 20142199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices.
    Krumsdorf U; Keppeler P; Horvath K; Zadan E; Schrader R; Sievert H
    J Interv Cardiol; 2001 Feb; 14(1):49-55. PubMed ID: 12053327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcatheter closure of patent foramen ovale using the Cocoon occluder: A multicenter retrospective study.
    Thanopoulos BVD; Bompotis GC; Deleanou D; Dardas P; Ninios V; Tsaousis GS; Trikas A; Saxpekidis V
    Hellenic J Cardiol; 2024; 75():21-25. PubMed ID: 37127207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder).
    Taaffe M; Fischer E; Baranowski A; Majunke N; Heinisch C; Leetz M; Hein R; Bayard Y; Büscheck F; Reschke M; Hoffmann I; Wunderlich N; Wilson N; Sievert H
    Am J Cardiol; 2008 May; 101(9):1353-8. PubMed ID: 18435971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic stroke.
    Luermans JG; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
    Neth Heart J; 2008 Oct; 16(10):332-6. PubMed ID: 18958256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patent foramen ovale using the Premere device: the results of the CLOSEUP trial.
    Büscheck F; Sievert H; Kleber F; Tiefenbacher C; Krumsdorf U; Windecker S; Uhlemann F; Wahr DW
    J Interv Cardiol; 2006 Aug; 19(4):328-33. PubMed ID: 16881979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical practice, resource utilization, and outcomes of device closure of patent foramen ovale in pediatrics.
    Menon SC; Grove A; McFadden M; Korgenski KE; Cowley CG
    Pediatr Neurol; 2014 Mar; 50(3):213-7. PubMed ID: 24433855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism.
    Kumor M; Biernacka EK; Demkow M; Konka M; Płatek AE; Jagodzińska M; Hoffman P
    Postepy Kardiol Interwencyjnej; 2014; 10(3):155-60. PubMed ID: 25489300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of PFO Anatomy on Successful Transcatheter Closure.
    Onorato E; Casilli F
    Interv Cardiol Clin; 2013 Jan; 2(1):51-84. PubMed ID: 28581988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late recognition of Gore Helex atrial septal occluder fracture and migration.
    Tyagi S; Patil H; Cinquegrani M; Pearson P; Joyce L; Garster N; Salinger M
    J Cardiol Cases; 2021 Sep; 24(3):140-143. PubMed ID: 34466179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term results of the amplatzer cribriform occluder for patent foramen ovale with associated atrial septal aneurysm: impact on occlusion rate and left atrial functional remodelling.
    Rigatelli G; Dell'avvocata F; Cardaioli P; Braggion G; Giordan M; Mazza A; Fraccaro C; Chinaglia M; Chen JP
    Am J Cardiovasc Dis; 2012; 2(1):68-74. PubMed ID: 22254216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multidisciplinary assessment of patients with ischemic stroke, the structure of a stroke team, and first Egyptian experience in adults undergoing transcatheter PFO closure for PFO-related stroke.
    Mansour A; Gamal NM; Elfiky AA; Saleh MA; Mohamed SA; ElKhawas HM; ElSadek A; Dawood NL; Elsayed MH
    Egypt Heart J; 2021 Mar; 73(1):21. PubMed ID: 33675437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the sizing balloon in selection of the patent foramen ovale closure device size.
    Alibegovic J; Bonvini R; Sigwart U; Dorsaz P; Camenzind E; Verin V
    Exp Clin Cardiol; 2008; 13(1):42-6. PubMed ID: 18650972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A remarkable case of late-onset biatrial bacterial endocarditis of the Gore HELEX septal occluder.
    Thiagaraj AK; Bloomingdale R; Telila T; Afonso LC
    J Cardiol Cases; 2017 Dec; 16(6):202-204. PubMed ID: 30279835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project.
    Testa L; Popolo Rubbio A; Squillace M; Albano F; Cesario V; Casenghi M; Tarantini G; Pagnotta P; Ielasi A; Popusoi G; Paloscia L; Durante A; Maffeo D; Meucci F; Valentini G; Ussia GP; Cioffi P; Cortese B; Sangiorgi G; Contegiacomo G; Bedogni F
    Front Cardiovasc Med; 2022; 9():1064026. PubMed ID: 36712245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rare Mechanical Complication of Percutaneous PFO Closure Leading to Recurrent Strokes in a Teenage Boy.
    Butt Z; Quinn S; McAdam B
    JACC Case Rep; 2021 Sep; 3(12):1456-1458. PubMed ID: 34557692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving migraine by means of primary transcatheter patent foramen ovale closure: long-term follow-up.
    Rigatelli G; Dell'avvocata F; Cardaioli P; Giordan M; Braggion G; Aggio S; L'erario R; Chinaglia M
    Am J Cardiovasc Dis; 2012; 2(2):89-95. PubMed ID: 22720197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helex Septal Occluder for Closure of Atrial Septal Defects.
    Latson LA; Zahn EM; Wilson N
    Curr Interv Cardiol Rep; 2000 Aug; 2(3):268-273. PubMed ID: 11096676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.